Denials are already one of the most persistent problems in the revenue cycle and anything that could impact the delicate machinery of denials management is worthy of trepidation. Consider this for a ...
Safety analysis of lurbinectedin versus topotecan in elderly patients. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract does not include a full text component.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback